Clinical trials on Prevention of Hypotension

  • CT-EU-00111386

    english (international) title

    Are you undergoing a Transcatheter Aortic Valve Implantation (TAVI) or MitraClip procedure? If so, you might be interested in a study focused on managing and predicting hypotension, a common issue during these procedures. The study is called “Is The Hypotension Probability Indicator With Goal Directed Haemodynamic Treatment Useful In Predicting And Treating Hypotension In Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) or MitraClip.”

    During surgery, it’s not uncommon for blood pressure to drop, a condition known as hypotension. This can lead to complications like acute kidney injury or myocardial injury. To address this, researchers are exploring a new approach using a tool called the Hypotension Probability Indicator (HPI). Developed by Edwards Lifesciences, the HPI uses continuous monitoring to predict drops in blood pressure before they happen, allowing for quicker responses to prevent hypotension.

    The study aims to see if using the HPI, along with a specific treatment plan focused on maintaining stable blood flow and pressure, can reduce the occurrence of hypotension and improve outcomes for patients undergoing TAVI or MitraClip procedures. This approach is based on the idea that managing blood pressure more effectively during surgery can help avoid complications and improve recovery.

    Participation in this study would involve monitoring your blood pressure closely during your procedure using the HPI tool, along with a tailored treatment plan to manage your blood pressure. The main thing researchers are looking at is how much time is spent with low blood pressure during the surgery and how the new approach might reduce this time.

    If you’re interested in potentially improving your surgery experience and contributing to research that could help others in the future, this study might be a good fit for you.